Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 06, 2014
Almac’s Diagnostics business unit today announced the presentation of an external validation of their ColDx signature for stage II colon cancer recurrence. Following publication of the initial validation study in the Journal of Clinical Oncology (JCO...
read more
Datatrak has chosen to partner with Sisense to provide data visualizations, Business Intelligence dashboards, predictive analytics, and real-time reporting for users of the Datatrak Enterprise Cloud.
read more
Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data exchange, announced that they have signed a definitive agreement to merge the two companies in a transaction valued at ...
read more
Datavant and Verge Genomics announced a strategic alliance to unlock the value of pharmaceutical datasets to accelerate drug discovery and development.
read more
Out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
read more
DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement.
read more
DDL, Inc. has implemented a GMP compliant quality system at its Irvine, CA laboratory to govern its container closure integrity testing (CCIT) division.
read more
Particle Sciences has broadened its Drug Enforcement Administration (DEA) registration to become an authorized manufacturer of Schedule I substances.
read more
The Drug Enforcement Administration (DEA) raided medical clinics, pharmacies and other locations across the South on Wednesday as part of a DEA attempt to thwart illegal prescription drug sales.
read more
Debiopharm has entered into a worldwide, exclusive license & research agreement with 3BP to further the development of their radioligand program which targets the CAIX enzyme.
read more
Debiopharm has been selected to receive a funding award from CARB-X to advance the development of its antibiotic Debio 1453, a FabI inhibitor specifically targeting N. gonorrhoeae.
read more
Debiopharm announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany for the development and commercialization of xevinapant.
read more
Debiopharm and Verity have entered into an exclusive agreement that grants Verity, in the U.S., the rights to commercialize Trelstar.
read more
Debiopharm and Ipsen announced renewal of their Decapeptyl® agreement, which extends their partnership through 2034 for the development, manufacturing and distribution of Decapeptyl®.
read more
“Frances Grote, Senior Director, Clinical Outsourcing at Millennium Pharmaceuticals is currently and has been one of our authors for years. She is a highly respected member of the pharmaceutical community and a frequent speaker and moderators at ...
read more